[SRNE] YoY Quarter Result on 30-Jun-2014 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
06-Aug-2014
Financial Year
2014
Quarter
30-Jun-2014 [#Q2]
Profit Trend
QoQ- 16.24%
YoY- -78.47%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Revenue 4,665 902 1,173 775 142 217 74 99.37%
PBT -16,137 -46,113 -10,975 -8,454 -4,737 -943 -1,088 56.68%
Tax -1,398 -1,164 -17 5 2 4 3 -
NP -14,187 -44,949 -10,958 -8,454 -4,737 -943 -1,088 53.35%
Tax Rate - - - - - - - -
Total Cost 18,852 45,851 12,131 9,229 4,878 1,160 1,162 59.04%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
NP Margin -304.12 -4,983.26 -934.19 -1,090.84 -3,345.11 -434.35 -1,466.69 -23.04%
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
EPS -0.20 -0.97 -0.30 -0.33 -0.35 -0.08 -0.11 10.46%
EPS Diluted -0.20 -0.97 -0.30 -0.33 -0.35 -0.08 -0.11 10.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.